Clinical Trials Logo
  1. Home
  2. Colon Cancer Liver Metastasis
  3. NCT03175016

Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer — DEBIRI-CRLM  

Colon Cancer Liver Metastasis Clinical Trial

Official title:
Irinotecan-Eluting Bead (DEBIRI) for Unresectable Liver Metastases From Colorectal Cancer After Systemic Chemotherapy Failure

Clinical Trial Summary

This is a multicentre, open labeled, single arm study to determine effectiveness and safety of chemoembolization with Irinotecan-Eluting Bead(DEBIRI) in the treatment of unresectable liver metastases in patients with colorectal cancer after chemotherapy failure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03175016
Study type Interventional
Source Tianjin Medical University Cancer Institute and Hospital
Contact Zhi Guo, PhD
Phone 13920076145
Email cjr.guozhi@vip.163.com
Status Recruiting
Phase Phase 2/Phase 3
Start date June 20, 2017
Completion date December 2019
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT01540435 - Perioperative Treatment of Resectable Liver Metastases Phase 2
Terminated NCT01464593 - Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) Phase 2
Completed NCT02090816 - Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy N/A
Recruiting NCT04682665 - Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases
Completed NCT01730365 - Optical Detection of Malignancy During Percutaneous Interventions N/A
Completed NCT01526200 - Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases N/A
Terminated NCT03370198 - Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer Phase 1
Completed NCT02781935 - Diffusion-Weighted MRI for Liver Metastasis
Completed NCT01891552 - Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab N/A
Recruiting NCT05293041 - Argipressin's Influence on Blood Loss During Hepatic Resection Phase 4
Recruiting NCT02631564 - Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis N/A
Recruiting NCT02363049 - Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer Phase 3
Recruiting NCT02557490 - Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases Phase 4
Completed NCT03415126 - A Study of ASN007 in Patients With Advanced Solid Tumors Phase 1
Recruiting NCT04668872 - Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Completed NCT01522209 - Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging N/A
Active, not recruiting NCT03310008 - Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases Phase 1